Aged Rats Are Susceptible to Nephrotoxicity Induced by Iodinated Contrast Media

REFERENCES

• Stacul F, van der Molen AJ, Reimer P, . Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527–2541.
   PubMed Web of Science ®Google Scholar
• Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol. 2004;44:1763–1771.
   PubMed Web of Science ®Google Scholar
• Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res. 2006;29:84–93.
   PubMed Web of Science ®Google Scholar
• Jerkić M, Vojvodić S, López-Novoa JM. The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I. The role of increased vasoconstriction. Int Urol Nephrol. 2001;32:539–547.
   PubMedGoogle Scholar
• Cronin RE. Contrast-induced nephropathy: pathogenesis and prevention. Pediatr Nephrol. 2010;25:191–204.
   PubMed Web of Science ®Google Scholar
• Vercellino M, Bezante GP, Balbi M. Contrast medium induced nephropathy: new insights into prevention and risk management. Cardiovasc Hematol Agents Med Chem. 2009;7:166–180.
   PubMedGoogle Scholar
• Carrillo-Alvira F, Rivera-Bermúdez CG, Jiménez-Velázquez IZ, Ramos-Romey C, González-Concepción JJ. Contrast associated nephropathy in the elderly. Bol Asoc Med P R. 2008;100:25–27.
   PubMedGoogle Scholar
• Katzberg RW. Contrast medium-induced nephrotoxicity: which pathway? Radiology. 2005;235:752–755.
   PubMed Web of Science ®Google Scholar
• Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol. 2004;44:1763–1771.
   PubMed Web of Science ®Google Scholar
• Duan SB, Liu FY, Luo JA, . Nephrotoxicity of high- and low-osmolar contrast media. The protective role of amlodipine in a rat model. Acta Radiol. 2000;41:503–507.
   PubMed Web of Science ®Google Scholar
• Russo D, Minutolo R, Cianciaruso B, Memoli B, Conte G, De Nicola L. Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol. 1995;6:1451–1458.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Lass NA, Glock D. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors. Kidney Int. 1999;56:206–210.
   PubMed Web of Science ®Google Scholar
• Rosenstock JL, Bruno R, Kim JK, . The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol. 2008;40:749–755.
   PubMed Web of Science ®Google Scholar
• Duan SB, Wu HW, Luo JA, Liu FY. Assessment of renal function in the early stages of nephrotoxicity induced by iodinated contrast media. Nephron. 1999;83:122–125.
   PubMed Web of Science ®Google Scholar
• Duan SB, Wang YH, Liu FY, . The protective role of telmisartan against nephrotoxicity induced by X-ray contrast media in rat model. Acta Radiol. 2009;50:754–759.
   PubMed Web of Science ®Google Scholar
• Leto TL, Morand S, Hurt D, Ueyama T. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal. 2009;11:2607–2619.
   PubMed Web of Science ®Google Scholar
• Heyman SN, Rosen S, Khamaisi M, Idée JM, Rosenberger C. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol. 2010;45:188–195.
   PubMed Web of Science ®Google Scholar
• Simão S, Gomes P, Pinto V, . Age-related changes in renal expression of oxidant and antioxidant enzymes and oxidative stress markers in male SHR and WKY rats. Exp Gerontol. 2011;46:468–474.
   PubMed Web of Science ®Google Scholar
• Capasso G, Di Gennaro CI, Della Raqione F, . In vivo effect of the natural antioxidant hydroxytyrosol on cyclosporine nephrotoxicity in rats. Nephrol Dial Transplant. 2008;23:1186–1195.
   PubMed Web of Science ®Google Scholar
• Park KM, Kim JI, Ahn Y, Bonventre AJ, Bonventre JV. Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem. 2004;279:52282–52292.
   PubMed Web of Science ®Google Scholar
• Golab F, Kadkhodaee M, Xu J, Soleimani M. Male susceptibility to hepatic damage in acute uremia in rats. Urology. 2011;78(232):e1–e6.
   PubMedGoogle Scholar
• Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv. 2008;71:62–72.
   PubMed Web of Science ®Google Scholar
• Presta P, Lucisano G, Fuiano L, Fuiano G. The kidney and the elderly: why does the risk increase? Int Urol Nephrol. 2012;44:625–632.
   PubMed Web of Science ®Google Scholar
• Andrade L, Campos SB, Seguro AC. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine. Kidney Int. 1998;53:1736–1742.
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007;100:460–473.
   PubMed Web of Science ®Google Scholar
• Corman B, Barrault MB, Klingler C, . Renin gene expression in the aging kidney: effect of sodium restriction. Mech Ageing Dev. 1995;84:1–13.
   PubMed Web of Science ®Google Scholar
• Lü X, Li X, Li L, Li L, Li C, Wang H. Variation of intrarenal angiotensin II and angiotensin II receptors by acute renal ischemia in the aged rat. Ren Fail. 1996;18:19–29.
   PubMed Web of Science ®Google Scholar
• Wong PC, Li Z, Guo J, Zhang A. Pathophysiology of contrast-induced nephropathy. Int J Cardiol. 2012;158:186–192.
   PubMed Web of Science ®Google Scholar
• Khanna AK, Pieper GM. NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrol Dial Transplant. 2007;22:376–385.
   PubMedGoogle Scholar
• Ahmad A, Mondello S, Di Paola R, . Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine. Eur J Pharmacol. 2012;674:397–406.
   PubMed Web of Science ®Google Scholar
• Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomised study. Indian Heart J. 1999;51:521–526.
   PubMedGoogle Scholar
• Shoda J, Kanno Y, Suzuki H. A five-year comparison of the renal protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with non-diabetic nephropathy. Intern Med. 2006;45:193–198.
   PubMed Web of Science ®Google Scholar